The Canadian cannabis market is abuzz with competition. The latest data from Hifyre, as analyzed by Zuanic & Associates, highlights a heated race in the pre-roll segment.
In the second quarter of 2023, a staggering 1,475 pre-roll SKUs were registered, originating from a diverse pool of 148 licensed producers (LPs). However, not all contenders are created equal, as 78 of these LPs held a mere 0.1% segment share or less.
Decibel vs. Tilray
Surging to the forefront, Decibel Cannabis Co Inc. DBCCF commands the pre-roll landscape with a 16% segment share, marking a significant ascent from its less than 5% share a year ago.
Decibel's rise underscores its savvy approach, with pre-rolls driving 65% of its total company sales in 2Q23.
Notably, 97% of Decibel's pre-roll sales in the second quarter stemmed from infused pre-rolls, a remarkable feat achieved through its 39 infused SKUs out of a total of 74.
Not far behind, Tilray TLRY claims a 13.8% share, a position fortified by its strategic acquisition of HEXO. Z&A explained this merger enabled Tilray to double its pre-roll segment share, even as it maintains a diversified portfolio with 161 SKUs listed.
A closer examination reveals that Redecan, a brand under Tilray's umbrella, contributes a substantial 39% of its pre-roll sales.
Infusion Triumph: Decibel's Surging Sales
Decibel's infusion strategy appears to have paid off handsomely, resulting in tripled pre-roll sales year-on-year for 2Q23. Despite Decibel's higher per-gram pricing, the market seems to be responding positively to its innovative offerings.
In contrast, Tilray's flagship brands, Aphria's Good Supply and Redecan, have experienced modest share erosion, presenting intriguing shifts within the market.
The numbers tell a compelling story of innovation, brand strength, and market response, leaving us to wonder – who will ultimately reign supreme as Canada's pre-roll champion?
Meet analyst Pablo Zuanic from Zuanic & Associates, in person, at the upcoming Benzinga Cannabis Capital Conference, the place where deals get done, which is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!